LEL-Fc blocks arthritis progression and bone destruction primarily by inhibiting inflammatory macrophage polarization, and the inflammatory response and RANKL expression in synovial fibroblast in joint inflammation, and subsequently inhibiting osteoclast precursor differentiation and osteoclast maturation associated with arthritis. The gene discussed is TNFSF11; the disease is arthritic joint disease.